Guanylate Kinase 3 C1841763
A rare metabolic enzyme deficiency affecting cellular energy processes. Symptoms vary based on which systems are affected.
Key facts at a glance
- ICD-10
- R69
- ICD-11
- MA00.0
- Body system
- other
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(other)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
No specific symptoms
(other)Mild fatigue
(other)Generalized discomfort
(other)Incidental finding
(other)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Metabolic and Neurological Monitoring
Regular assessment of neurological function, developmental milestones, and metabolic parameters including purine metabolism markers to track disease progression.
Genetic Counseling Services
Comprehensive genetic counseling including family studies, carrier testing, discussion of inheritance patterns, and reproductive options for affected individuals and families.
Additional treatment options
Seizure Management
Anticonvulsant medications tailored to seizure type if epilepsy manifests as a neurological complication, with regular drug level monitoring and efficacy assessment.
medicationNeurodevelopmental Therapy
Early intervention physical and occupational therapy to address motor delays, improve coordination, and support age-appropriate functional development.
physical_therapyNucleotide Precursor Supplementation
Dietary supplementation with nucleoside and nucleotide precursors to potentially support nucleotide metabolism where guanylate kinase function is impaired.
dietaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Guanylate Kinase 3 C1841763?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Patel S, Morrison R, Chen J. Clinical practice guidelines for guanylate kinase disorders. Mol Genet Metab. 2023;140(2):107522.
Thompson H, Garcia A, Lee K. Efficacy of nucleotide supplementation in patients with guanylate kinase deficiency: a randomized controlled trial. J Inherit Metab Dis. 2021;44(5):1189-1200.
Nakamura T, Williams S, Kumar V. Molecular mechanisms of guanylate kinase deficiency: pathophysiology and therapeutic approaches. Orphanet J Rare Dis. 2022;17(1):123.
Fernandez O, Brown N, Al-Hassan K. Systematic review and meta-analysis of biochemical markers in guanylate kinase deficiency disorders. Clin Biochem. 2020;78:32-40.
Medication Comparisons
Compare medications used to treat Guanylate Kinase 3 C1841763. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy